Ethics & Standards

Asimov Press is an editorially-independent publisher of digital magazines and books about biotechnology. We are funded by Asimov, a biotechnology company in Boston. But Asimov, the company, has no editorial control over what Asimov Press publishes. The Press does not publish pieces about Asimov or its commercial interests.

All pieces published by Asimov Press solely represent the opinions of their authors. None of our articles claim complete objectivity, and none necessarily represent the views of our Editors or Asimov Press’ funders. 

All of our articles are free to read. Asimov Press does not publish sponsored content or use paywalls. We aim to publish well-evidenced, narrative, contextual articles that will stand the test of time and continue to be read long after they were written. 

‍Corrections: Pieces published in our quarterly issues are copy-edited and fact-checked. Asimov Press will revise and correct any factual errors later discovered. Corrections will appear at the end of articles and clearly state what was wrong in the original article and how we have corrected it. Corrections may include names and dates or deeper errors. We do not make distinctions between corrections, clarifications, and editors’ notes. We will not issue corrections for spelling and punctuation errors.

Due to the speculative nature of some of the topics covered in Asimov Press, it will not always be possible to definitively verify facts. In some cases, authors must make a judgment based on a cited body of evidence and will use appropriate language to express their degree of uncertainty. At times, readers will have opinions that differ from those of our authors and we at the Press embrace the resulting discourse. 

We will not tolerate plagiarism. Depending on the severity, we will correct or withdraw pieces with plagiarized elements. 

‍Fairness: Asimov Press articles strive to be fair and charitable. That means they are written using reasonable epistemic standards and fairly and accurately describe ideas that they disagree with. All articles should put biotechnology solutions in context, compare them to alternative ways to accomplish the same ends and steelman the alternatives.

‍AI: We do not currently have policies regarding the use of AI tools to supplement the research or writing process.